DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on August 23, 2006; DOI: 10.1124/dmd.106.010876


0090-9556/06/3411-1868-1874$20.00
DMD 34:1868-1874, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.010876v1
34/11/1868    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohta, K.-y.
Right arrow Articles by Yuasa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohta, K.-y.
Right arrow Articles by Yuasa, H.

Molecular Identification and Functional Characterization of Rat Multidrug and Toxin Extrusion Type Transporter 1 as an Organic Cation/H+ Antiporter in the Kidney

Kin-ya Ohta, Katsuhisa Inoue, Yayoi Hayashi, and Hiroaki Yuasa

Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan

We have cloned and functionally characterized the rat ortholog of multidrug and toxin extrusion type transporter 1 (rMATE1). The mRNA of rMATE1 was strongly expressed in kidney and detectable in the various tissues such as brain, stomach, colon, lung, liver, spleen, skeletal muscle, and prostate. When stably expressed in HEK293 cells, rMATE1 could mediate the transport of tetraethylammonium (TEA) and cimetidine under the condition where the membrane potential was disrupted by a high concentration of potassium ion and intracellular pH was reduced by NH4Cl pretreatment. When extracellular pH was changed from 5.5 to 8.5, the transport of TEA by rMATE1 was greatest at pH 7.5. Kinetic analyses showed that the transports of TEA and cimetidine mediated by rMATE1 were both saturable with a Km of 260 ± 10 and 3.01 ± 0.21 µM, respectively. It was found that cimetidine is the most potent inhibitor of rMATE1, and many other organic cations, such as 1-methyl-4-phenylpyridinium, amiloride, imipramine, and quinidine, are also effective as inhibitors. Pretreatment of the cells expressing rMATE1 with p-chloromercuribenzene sulfonate significantly reduced TEA transport, but this effect was totally reversed by subsequent treatment with dithiothreitol. These results indicate that the functional nature of rMATE1 is consistent with that of the hypothetical organic cation/H+ antiporter system in the brush-border membrane of the renal tubular epithelial cells. Accordingly, these results suggest that rMATE1 is an electroneutral and multispecific organic cation transporter energized by the trans-proton gradient, and plays a physiological role in renal secretion of organic cations, including clinically used cationic drugs.


Address correspondence to: Dr. Katsuhisa Inoue, Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan. E-mail: kinoue{at}phar.nagoyacu.ac.jp




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
T. Okura, A. Hattori, Y. Takano, T. Sato, M. Hammarlund-Udenaes, T. Terasaki, and Y. Deguchi
Involvement of the Pyrilamine Transporter, a Putative Organic Cation Transporter, in Blood-Brain Barrier Transport of Oxycodone
Drug Metab. Dispos., October 1, 2008; 36(10): 2005 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
W. R. Proctor, D. L. Bourdet, and D. R. Thakker
Mechanisms Underlying Saturable Intestinal Absorption of Metformin
Drug Metab. Dispos., August 1, 2008; 36(8): 1650 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Matsuzaki, T. Morisaki, W. Sugimoto, K. Yokoo, D. Sato, H. Nonoguchi, K. Tomita, T. Terada, K.-i. Inui, A. Hamada, et al.
Altered Pharmacokinetics of Cationic Drugs Caused by Down-Regulation of Renal Rat Organic Cation Transporter 2 (Slc22a2) and Rat Multidrug and Toxin Extrusion 1 (Slc47a1) in Ischemia/Reperfusion-Induced Acute Kidney Injury
Drug Metab. Dispos., April 1, 2008; 36(4): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Matsumoto, T. Kanamoto, M. Otsuka, H. Omote, and Y. Moriyama
Role of glutamate residues in substrate recognition by human MATE1 polyspecific H+/organic cation exporter
Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1074 - C1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Hiasa, T. Matsumoto, T. Komatsu, H. Omote, and Y. Moriyama
Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter
Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1437 - C1444.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Kajiwara, T. Terada, J.-i. Asaka, K. Ogasawara, T. Katsura, O. Ogawa, A. Fukatsu, T. Doi, and K.-i. Inui
Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1564 - F1570.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-i. Asaka, T. Terada, M. Tsuda, T. Katsura, and K.-i. Inui
Identification of Essential Histidine and Cysteine Residues of the H+/Organic Cation Antiporter Multidrug and Toxin Extrusion (MATE)
Mol. Pharmacol., June 1, 2007; 71(6): 1487 - 1493.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.